Partnerships in Clinical Trials Expands Its Global Reach

NEW YORK--(Business Wire)--
The Institute for International Research is pleased to announce that as a chief
component of its global branding strategy, the industry-leading Partnerships
with CROs event is now known as Partnerships in Clinical Trials. In the nineteen
years since the inception of the event, both the biopharmaceutical industry and
Partnerships have experienced tremendous growth as outsourcing to suppliers has
become more than simply a tactic to control costs, but a leading strategic
directive to ensure speed, quality and value of new medicines. "The name
Partnerships in Clinical Trials reflects the comprehensive nature of the
program, which is the must-attend annual event for clinical outsourcing and
development professionals and is increasingly valuable to those with
responsibilities in clinical operations, clinical project management, drug
safety and quality," said program director Lesly Atlas. "Our new name also
represents our widening global reach with Partnerships in Clinical Trials events
already taking place in Europe and the premier of our APAC event in Singapore
this December. Collectively the Partnerships in Clinical Trials brand serves
over 35 countries."

Notable speakers include:

* Tom Daschle, Former Senate Majority and Minority Leader, US Senate
* David Holveck, President and CEO, Endo Pharmaceuticals
* Nancy Simonian, MD, Chief Medical Officer and Senior Vice President of
Clinical, Medical, and Regulatory Affairs, Millennium: The Takeda Oncology
Company
* Ethan Zohn, Winner of Survivor: Africa Chris Anderson, Editor-in-Chief, Wired
Magazine and NYT Bestselling Author, The Long Tail: Why the Future of Business
is Selling Less of More
* Thomas Senderovitz, MD, Vice President, Global Exploratory Development, UCB
Pharma - Belgium
* Jason Hwang, MD, Executive Director, Innosight Institute
* Deirdre BeVard, Vice President, Clinical Operations and Data Management, Endo
Pharmaceuticals
* Reinilde Heyrman, Vice President, Clinical Development and Operations, Daiichi
Sankyo Pharma Development
* Peter Carberry, Senior Vice President, Global Development Operations, Astellas
Pharmaceuticals
* Kenneth Getz, Senior Research Fellow, Tufts Center for the Study of Drug
Development
* John Balian, MD, Senior Vice President, Global Pharmacovigilance and
Epidemiology, BRISTOL-MYERS SQUIBB
* Amrit Ray, MD, MBA, FCMI, Chief Safety Officer, Head, Global Medical Safety,
JOHNSON & JOHNSON PHARMACEUTICALS GROUP
* Philippe Van der Auwera, MD, PhD, Global Head of Safety Risk Management (PDS)
& EU-QPPV, Pharma Development, F.HOFFMANN-LA ROCHE LTD - Switzerland
* Mariette Boerstoel-Streefland, MD, MBA, MS(epi), Chief Safety Officer, Vice
President, Global Drug Safety, FOREST RESEARCH INSTITUTE
* Juergen Schmider MD, PhD, Corporate Safety Officer and Vice President Global
Pharmacovigilance & Epidemiology, CEPHALON, INC
* And many more - complete program information will soon be available at
www.clinicaltrialpartnerships.com.

About Partnerships in Clinical Trials - Partnerships is the leading drug
development event bringing clinical trials executives timely information and
trends in sourcing models and successfully maintaining critical sponsor/provider
relationships, as well as valuable best practices and networking for entire
clinical teams. As the number one meeting place for clinical trial partners to
gather under one roof, Partnerships in Clinical Trials is known for strategic
program content that drives business forward and for unparalleled networking.
Visithttp://www.centrallabswest.com/www.clinicaltrialpartnerships.com for more
information.

To inquire about speaking, sponsoring or attending Partnerships in Clinical
Trials, please contact Allison Rigels via email at ARigels@iirusa.comor phone at
646-895-7327.

IIR
Allison Rigels, 646-895-7327
Marketing Manager
ARigels@iirusa.com

Copyright Business Wire 2009